Introduction
Stroke is among the leading causes of death in the world and a common cause of disability (Feigin et al., 2009; Bevan and Markus, 2011) . Its incidence is rising with increasing life expectancy, although about 20% of strokes occur before the age of 65. Ischemic stroke (IS) is a heterogeneous multi-factorial, polygenic, complex disease resulting from the combination of vascular, environmental and genetic factors (Kim et al., 2012) . Inflammation and genetics are both prominent mechanisms in the pathogenesis of ischemic stroke (Jin et al., 2010) . Candidate genes, stroke susceptible alleles and their association with stroke pathogenesis have been intensively studied in the last few years (Carr et al., 2002; Hansson, 2005; Takashima et al., 2007) .
Numerous epidemiological studies in twins and families have revealed that the genetic factors in addition to other risk factors are involved in the predisposition of stroke. Recent findings have suggested that variations in the pro and anti-inflammatory cytokine genes may be associated with the risk of stroke. The genes encoding interleukin-1α (IL-1α), CD14 cell surface glycoprotein (CD14), galectin-2-encoding gene (LGALS2) and proteasome subunit type 6 (PSMA6), all of which are involved in the inflammatory mechanisms, were reported to be involved in the pathogenesis of cerebrovascular diseases (Takashima et al., 2007; Ozaki et al., 2006; Um et al., 2003; Wright et al., 1990; DeGraba, 2004) .
CD14 is a receptor for bacterial lipopolysaccharide (LPS, endotoxin), and it mediates cell activation by LPS, while IL-1α acts as a proinflammatory cytokine which contributes to atherogenesis. Increased activity of PSMA6 activates the nuclear factor КB (NF-КB). (NF-КB) is a central transcription factor that regulates the expression of the genes of adhesion molecules and cytokines which are involved in atherogenesis.
LGALS2 gene C3279T is encoded by galectin-2 which is thought to reduce the transcriptional level of galectin-2, and also play a role in protection against myocardial infarction. The single nucleotide polymorphisms (SNPs) present in the genes CD14 (-C260T), IL-1α (-C511T, -C889T), LGALS2 (-C3279T) and PSMA6 (-C8G) respectively, were found to be associated with increased risk of cardiovascular diseases in different populations, but limited studies have been published so far examining these SNPs and their association with susceptibility for IS.
Since a single study may not prove to be sufficient in providing reliable conclusions because of the presence of small amounts of subjects and weight age of statistical and clinical heterogeneities, therefore, we carried out this meta-analysis, which combines the eligible published literatures based on quantitative synthesis to obtain a more convincing assessment of the association between these inflammatory gene polymorphisms and risk of IS.
Materials and methods

Identification of relevant studies
A literature search for eligible candidate gene studies published before August 31, 2015 was conducted in the PubMed, Medline, EMBASE, OVID and Google Scholar databases. The following combinations of main keywords were used: ('Interleukin-1 alpha' or 'IL-1α' or 'IL1F1') and ('CD14 cell surface glycoprotein' or 'CD14') and ('Galectin-2-encoding gene' or 'LGALS2' or 'HL14') and ('proteasome subunit type 6' or 'PSMA6') and ('ischemic stroke' or 'cerebral infarction' or 'IS') and ('genetic polymorphism' or 'single nucleotide polymorphisms' or 'SNP'). Fixed or random effects models were used to estimate the Pooled Odds ratio (OR) and 95% confidence interval (CI). Begg's funnel plot was used to assess the publication bias in the studies. Metaanalysis was carried out by using RevMan 5.3 software.
Inclusion and exclusion criteria
To be included in the analysis, eligible studies have to meet the following criteria: (1) case-control studies on the association between the IL-1α (-C889T or -C511T); CD14 (-C260T); LGALS2 (-C3279T); PSMA6 (-C8G) genetic polymorphisms and susceptibility to IS; (2) all patients in the candidate studies meet the diagnostic criteria for IS; (3) studies with sufficient available data to calculate ORs with corresponding 95% CIs. The major reasons for excluding studies were:
(1) not a case-control study; (2) duplicate publications with overlapping subjects from the same study; and (3) no available data reported. This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline (Moher et al., 2009) . No author was contacted regarding the missing information that was required for the meta-analysis to avoid the risk of retrieval bias.
Data extraction
According to the PRISMA guidelines, two investigators independently SM and PK checked each full-text report for eligibility and extracted the following data from eligible studies: surname of first author, year of publication, country of origin, ethnicity, definition and number of case and control, age, sex ratio, genotyping method and genotype frequency, etc. Disagreements were solved by discussion between all authors until consensus was reached.
Quality assessment
We also evaluated the methodological quality of every study which is included in our analysis using a quality assessment scale developed for genetic association studies (Attia et al., 2003) which was modified by us to increase the relevance of our study. This scale took into account both traditional epidemiological considerations and genetic issues. The scores ranged from 0 (worst) to 16 (best). Details of the scale are presented in Table 1 . Two authors independently assessed the quality of included studies. Discrepancies over quality scores were resolved by discussion among all the authors and subsequent consensus was reached.
Statistical analysis
Genotype distributions in the controls were tested for confirmation to Hardy-Weinberg equilibrium (HWE) using the chi-square test. The association between the inflammatory genetic polymorphisms and susceptibility to IS was assessed by the pooled OR with their corresponding 95% CI under two genetic models, including dominant and recessive models. Taking into consideration possible heterogeneity between-study, a statistical test for heterogeneity was first conducted using Cochran's Q statistic and I 2 metric (Higgins et al., 2003) . We considered the presence of significant heterogeneity at the 10% level of significance and values of I 2 exceeding 50% as an indicator of significant heterogeneity. When no heterogeneity was found with P b 0.10 or I 2 , 50%, a fixed-effect model was used to estimate the pooled ORs and 95% CIs. Otherwise, a random-effect model was applied. Begg's funnel plot was used to assess the potential for publication bias.
Results
A total of 99 published articles were identified by using the prespecified search strategy. Fig. 1 depicts a flow chart of both the retrieved and excluded studies with their reasons for exclusion. Out of 99 retrieved articles, 42 studies were excluded due to its irrelevancy to our interest and 9 studies were excluded as they were in duplicate records. Keeping the inclusion criteria in mind, 21 case-control studies were included in our meta-analysis. Studies were carried out in two major ethnic populations; 9 studies were in Asian and the other 11 studies were in Caucasian population. The publication years of the included studies ranged from 2000 to 2013. 17 studies in this meta-analysis had controls in HWE. The quality scores of all included studies were moderately high. Out of 21 studies, 8 studies had hospital based and 13 studies had population based source of controls. Begg's funnel plot suggested significant publication bias in the studies (Fig. 3) . Table 2 gives a summary of the characteristics and methodological quality of all the included studies. (Fig. 2) .
For C511T, 10 case-control studies with a total of 2718 IS patients and 2748 controls showed a non-significant association with susceptibility to IS under dominant [TT + TC vs. CC: OR = 0.95, 95% CI: 0.66-1.37, P = 0.77] and recessive models [TT vs. CC + TC: OR = 1.17, 95% CI: 0.88-1.54, P = 0.28] (Fig. 2) . Fig. 1 . Flow diagram of the selection of studies and specific reasons for exclusion from the present meta-analysis. Abbreviations: PCR -polymerase chain reaction; RFLP -restriction fragment length polymorphism; M -male; F -female; NA -not available; PB -population based; HB -hospital based; MALDI-TOF -matrix assisted laser desorption ionizationtime of flight; and HWE -Hardy Weinberg equilibrium. (Fig. 2) . (Fig. 2) . (Fig. 2) .
Discussion
In our comprehensive meta-analysis, five SNPs of four genes involving 21 studies with 6216 IS cases and 6539 controls were analyzed. Our findings suggest that the variants in the inflammatory genes did not show any significant association with the risk of IS. No significant association was observed under both dominant and recessive models of IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and dominant model of PSMA6 (-C8G) gene polymorphisms with the risk of IS. However, the recessive model of PSMA6 (-C8G) gene polymorphism showed a protective level of association with susceptibility to IS. Our findings are consistent with the recently published meta-analysis of IL-1α showing no significant association with the risk of IS for C511T, however Zou et al. (2015) concluded that IL-1α (-C889T) was found to be associated with the risk of IS (Zou et al., 2015) . Previous metaanalysis by Ye et al. (2012) also showed no association for IL-1α (C889T and C511T) with the risk of IS in overall population. But, T allele of IL-1α C511T showed a 1.97 fold risk of IS in Polish population compared with the control group. It may be possible that the effect of IL-1α C511T polymorphism on IS risk might be modified by age or other unknown factors (Ye et al., 2012) . Meta-analysis published by Pu et al. (2013) suggested that CD14 (-C-260T) polymorphism is a risk factor of coronary heart disease (CHD), especially in East Asians (Pu et al., 2013) .
Our meta-analysis is the first meta-analysis to report the association of inflammatory gene polymorphisms with the risk of IS to the best of our knowledge. Overall findings did not observe any significant association between IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and PSMA6 (-C8G) gene polymorphisms and risk of IS. The present meta-analysis must be interpreted with caution because of certain limitations. First, the studies included in meta-analysis were varied in ethnicity, age and environmental factors. Second, the use of different methodologies for genotyping method, selection of controls and matching criteria may have lead to heterogeneity. Therefore, more credible evidences are required to illustrate solid conclusions on the association between inflammatory gene polymorphisms and risk of IS.
In summary, our meta-analysis shows that IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and gene polymorphisms are not significantly associated with the risk of IS while PSMA6 (-C8G) gene polymorphism may play a protective role with the susceptibility of IS. Further prospective large epidemiological studies are needed to confirm these findings. 
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